Rheumatology Advance Access published online on February 10, 2005
Rheumatology, doi:10.1093/rheumatology/keh562
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Rheumatology, Dijon University Hospital, Dijon, France
* To whom correspondence should be addressed.
Accepted January 5, 2005
Letters to the Editor
Survival and safety of treatment with infliximab in the elderly population
2 Department of Medicine and Rheumatology, J. Bouveri Hospital, Montceau les Mines, France
3 Department of Rheumatology, Hôtel Dieu Hospital, Le Creusot, France
4 Department of Rheumatology, G. Ramon Hospital, Sens, France
5 Department of Rheumatology, Dijon University Hospital, Dijon, France; INSERM/ERIT-M 0207, University of Burgundy, Dijon, France
J. F. Maillefert, E-mail: jean-francis.maillefert{at}chu-dijon.fr
![]()
CiteULike
Connotea
Del.icio.us What's this?